Meyling Cheok

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

Monique L. den Boer, Marjon van Slegtenhorst, Renée X. de Menezes et al. · The Lancet Oncology · 2009 · 915 citations · Full text

Hematological Malignancy, Poor Treatment Outcome, Pediatric Hematology +12

A 17-gene stemness score for rapid determination of risk in acute leukaemia

Stanley Ng, Amanda Mitchell, Theodore A. Kennedy et al. · Nature · 2016 · 887 citations

Hematological Malignancy, Acute Leukaemia, 17-Gene Stemness Score +13

Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment

Amy de Haar-Holleman, Meyling Cheok, Monique L. den Boer et al. · New England Journal of Medicine · 2004 · 643 citations · Full text

A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia

Andy G.X. Zeng, Suraj Bansal, Liqing Jin et al. · Nature Medicine · 2022 · 312 citations

Hematological Malignancy, Engineering, Tumor Heterogeneity +14

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)

Olivier Kosmider, Véronique Gelsi‐Boyer, Meyling Cheok et al. · Blood · 2009 · 269 citations